Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

13.80
BATS BZX Real-Time Price
As of 12:01pm ET
 -0.53 / -3.70%
Today’s Change
3.68
Today|||52-Week Range
27.79
+5.99%
Year-to-Date
No recent news for Achaogen Inc.

Today’s Trading

Previous close14.33
Today’s open14.51
Day’s range13.75 - 14.51
Volume24,255
Average volume (3 months)741,304
Market cap$605.2M
Dividend yield--
Data as of 12:01pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-101.34%
Earnings growth (this year)+2.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.29%
P/E ratioNM
Price/Sales7.39
Price/Book4.78

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...+0.98+3.08%
AKBAAkebia Therapeutics ...+0.10+0.56%
CYTKCytokinetics Inc+0.15+1.01%
PRTKParatek Pharmaceutic...-0.10-0.43%
Data as of 12:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$41.8M
Annual profit (last year)-$71.2M
Net profit margin-170.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Kenneth J. Hillan
President &
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts